AZILECT 1 mg, tablet 30 tablets
Brand page: Azilect (rasagiline) — all forms and strengths in France
Active ingredients: Rasagiline mesylate, Rasagiline
Commercialized according to BDPMDispensing in France: Prescription only
Tablet30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- AZILECT 1 mg, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) aluminium de 30 comprimé(s)
- Marketing authorisation holder
- TEVA (PAYS-BAS)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 6 Feb 2009
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62722988CIP73657835CIP133400936578357Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MÉSILATE DE RASAGILINEcomprimé | 1,56 mg · un comprimé | SA |
| RASAGILINEcomprimé | 1 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.